Rituximab for aggressive non-Hodgkin's lymphomas relapsing after or refractory to autologous stem cell transplantation

Dorothy PAN; Craig H MOSKOWITZ; Andrew D ZELENETZ; David STRAUS; Tarun KEWALARAMANI; Ariela NOY; JING JING QIN; Julie TERUYA-FELDSTEIN; Carol S PORTLOCK

doi:10.1097/00130404-200209000-00007

$Rituximab for aggressive non-Hodgkin's lymphomas relapsing after or refractory to autologous stem cell transplantation$

Journal article

Peer reviewed

Rituximab for aggressive non-Hodgkin's lymphomas relapsing after or refractory to autologous stem cell transplantation

Dorothy PAN, Craig H MOSKOWITZ, Andrew D ZELENETZ, David STRAUS, Tarun KEWALARAMANI, Ariela NOY, JING JING QIN, Julie TERUYA-FELDSTEIN and Carol S PORTLOCK

The cancer journal (Sudbury, Mass.), Vol.8(5), pp.371-376

2002

DOI: https://doi.org/10.1097/00130404-200209000-00007

PMID: 12416894

Abstract

Biological and medical sciences

Medical sciences

Antineoplastic agents

Immunotherapy

Pharmacology. Drug treatments

Metrics

12 Record Views

18 Times Cited - Web of Science

See more details

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration
Citation topics: 1 Clinical & Life Sciences; 1.130 Lymphomas; 1.130.132 Lymphoma
Web Of Science research areas: Oncology
ESI research areas: Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Details

Title: Rituximab for aggressive non-Hodgkin's lymphomas relapsing after or refractory to autologous stem cell transplantation
Creators: Dorothy PAN - Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Craig H MOSKOWITZ - Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Andrew D ZELENETZ - Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, United States
David STRAUS - Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Tarun KEWALARAMANI - Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Ariela NOY - Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, United States
JING JING QIN - Department of Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Julie TERUYA-FELDSTEIN - Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Carol S PORTLOCK - Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Publication Details: The cancer journal (Sudbury, Mass.), Vol.8(5), pp.371-376
Publisher: Jones and Barlett; Sudbury, MA
Academic Unit: Miller School of Medicine; UMMG Department of Medicine
Language: English
Resource Type: Journal article
PMID: 12416894
Record Identifier: 991031562098502976